April Is A Good Prescription For Pharmaceuticals


The seasonality tool here at provides an easy way to review historical results for indices, sectors, industry groups and individual stocks.  I looked at financials and healthcare industry groups as these two sectors have performed the worst over the past three months.  Perhaps seasonal strength can provide a "cure" for pharmaceuticals ($DJUSPR), which have clearly been under the weather.  Here's the historical view of pharmas, broken down by average calendar month returns over the past 17 years:

There are a couple points to be made here.  First, note that the DJUSPR has risen 71% of the time during the month of April and that's the highest percentage among all calendar months.  Second, toward the bottom of the chart, you can see that the average monthly return for April over the 17 year period is 1.7% and that's the highest average monthly return as well.

Now let's turn our attention to the current technical picture to see if the group is likely to strengthen:

Momentum has obviously been very weak over the past several months.  A negative divergence emerged on the weekly chart in the spring of 2015 and the DJUSPR has struggled since.  It's why I pay such close attention to weekly negative divergences as they tend to mark significant tops.  The weekly MACD is currently pointing higher so a push and close above the 20 week EMA, currently at 481, would be a solid first step toward continuing strength in April.

Happy trading!



Tom Bowley
About the author: is the Chief Market Strategist at, where he provides stock market education, guidance, and trading strategies using a unique combination of technical, fundamental, and historical analysis. Tom provides members with four portfolios (Model, Aggressive, Income, and Value), all designed to beat the benchmark S&P 500, and a revolving Watch List of hundreds of companies reporting strong quarterly earnings (must beat both revenue and EPS estimates) and exhibiting technical strength as well. These companies comprise EarningsBeats' annotated Strong Earnings ChartList (SECL), from which Tom trades exclusively. Tom writes a Daily Market Report (DMR) for members to include an executive summary, market outlook, sector/industry watch, and trading ideas. Learn More
Subscribe to ChartWatchers to be notified whenever a new post is added to this blog!
comments powered by Disqus